Bielefeld Pubmetadata only
First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials
escc, esophageal squamous cell carcinoma, immunotherapy, meta-analysis, overall survival, pd-1 inhibitor, pd-l1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 991168
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.